Amber Tong is a senior editor at Endpoints News. In addition to writing on the biggest scientific and business updates of the day, she steers coverage decisions for the newsroom and sets the agenda before the US and Europe are awake. She has a particular focus on oncology, and how technologies developed for cancer are being used in other diseases. Working out of Hong Kong, she has also helped bring attention to the growing role Asia plays on the global biopharma stage. Amber is a graduate of Rice University, with a degree in anthropology, and has lived in Houston and Sheffield.